General Biologicals Corporation announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 318.101 million compared to TWD 164.834 million a year ago. Operating income was TWD 53.717 million compared to operating loss of TWD 2.140 million a year ago. Net income was TWD 52.364 million compared to net loss of TWD 2.571 million a year ago. Basic earnings per share was TWD 0.88 compared to basic loss per share of TWD 0.05 a year ago.